4//SEC Filing
Shohet Stephen B. 4
Accession 0001104659-17-069497
CIK 0001297184other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:02 PM ET
Size
8.8 KB
Accession
0001104659-17-069497
Insider Transaction Report
Form 4
Shohet Stephen B.
Director
Transactions
- Exercise/Conversion
Common Stock
2017-11-16$10.77/sh+7,862$84,674→ 31,978 total - Sale
Common Stock
2017-11-16$18.04/sh−7,862$141,862→ 24,116 total - Exercise/Conversion
Stock Option (right to buy)
2017-11-16−7,862→ 31,452 totalExercise: $10.77Exp: 2017-12-15→ Common Stock (7,862 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.91 to $18.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Shares subject to the option are fully vested and immediately exercisable.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001611281
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 8:02 PM ET
- Size
- 8.8 KB